Archives: Resources
The 2025 State of FSP Outsourcing: Challenges, Trends and Opportunities, and the Future of FSP Strategies and Models
Discover how FSP and hybrid FSP/FSO models are helping sponsors better navigate clinical development outsourcing.
Real-world evidence studies – Diverse Data Designs
In close collaboration with sponsors, we identify and understand multi-stakeholder evidence needs across the product lifecycle.
US inflation reduction act: pipeline considerations
A risk exposure framework for drug developers.
Navigate the EU HTA Regulation
Trusted partner with 30+ years of experience in EU HTA, aiding health tech developers through EU HTA Regulation complexities.
Registries and Real-world Evidence
Customizable registry solutions for actionable insights, tailored study design, and regulatory-grade data to accelerate development.
Peri- and Post-approval Safety and Real-world Insights
Learn how we optimize post-authorization safety obligations with a holistic, collaborative, and custom study design approach.
Advancing Rare Disease Treatments in the COVID-19 Era and Beyond
Read our white paper on the continued interest in developing treatments for rare diseases.
Pediatric Drug Development: Trends in the EU
A discussion on Pediatric Investigation Plans (PIPs), a 10-year report on the impact of the Regulation, and pediatric clinical trials.